You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Shuhang Zhang1, Weilang Wang1, Wu Cai2
1Department of Radiology, Zhongda Hospital, Nurturing Center of Jiangsu Province for State Laboratory of AI Imaging & Interventional Radiology, School of Medicine, Southeast University, Nanjing, China.
A new fusion model combining radiomics and radiologic features accurately predicts early recurrence locations in nonviable hepatocellular carcinoma (HCC) after transarterial chemoembolization (TACE). This approach aids in personalized follow-up and retreatment planning for HCC patients.
09:49Dual-phase Cone-beam Computed Tomography to See, Reach, and Treat Hepatocellular Carcinoma during Drug-eluting Beads Transarterial Chemo-embolization
Published on: December 2, 2013
09:11Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma
Published on: May 24, 2024
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: